RetinalGenix Technologies Inc. RTGN
3.99 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
4.00 Day range 4.00
3.20 52-week range 4.00
- YTD
- +24.69%
- 1 year
- +12.39%
News
globenewswire.com RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study RetinalGenix's core thesis—that combining high‑resolution imaging, genetics, and advanced analytics may unlock new insights into ocular and systemic health
globenewswire.com RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO APOLLO BEACH, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging…
globenewswire.com RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases APOLLO BEACH, Fla. , Oct. 16, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] ("RetinalGenix" or the "Company"), a company developing ultra-high-resolution retinal imaging…
globenewswire.com RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases APOLLO BEACH, Fla. and HUNTINGTON, W.Va.
globenewswire.com RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care APOLLO BEACH, Fla., Sept. 25, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), a pioneering developmental-stage ophthalmic monitoring and…
globenewswire.com RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening APOLLO BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic…
globenewswire.com RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives Appointment Underscores RetinalGenix's Commitment to Integrating the Latest Advances in Genomics and Personalized Medicine into its Product Pipeline Appointment Underscores RetinalGenix's Commitment…
globenewswire.com RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs Company to use facility to further development of RetinalGenix's therapies for neurodegenerative and retinal diseases Company to use facility to further development of RetinalGenix's therapies for…
globenewswire.com RetinalGenix Technologies to Participate at the 37th Annual Roth Conference RetinalGenix Technologies to Participate at 2025 Roth Conference and will discuss patented remote monitoring high-resolution retinal imaging and biomarkers
globenewswire.com RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring RETINALGENIX TECHNOLOGIES BREAKTHROUGH IN REAL-TIME 24/7 REMOTE OCULAR MONITORING High-Resolution Retinal Imaging Using Both Near Infrared And Green Modes
globenewswire.com RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy PETALUMA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) today announced that it has been granted a patent by the United…
globenewswire.com RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration RETINALGENIX AND MEDSAN CONTRACT TO ADVANCE STUDY INTENDED TO PERSONALIZE MEDICAL EVALUATIONS FOR PATIENTS RECEIVING TREATMENT FOR WET MACULAR DEGENERATION
globenewswire.com RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company's Medical Advisory Board PETALUMA, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB: RTGN) (“RetinalGeniX” or the “Company”), today announced that Anatoly Dritschilo, M.D.
globenewswire.com RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors RETINALGENIX TECHNOLOGIES INC. APPOINTS DESSY BONEVA, MD, FACS TO THE BOARD OF DIRECTORS Dr. Boneva is an experienced surgeon skilled in trauma, surgical
globenewswire.com RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO PETALUMA, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB: RTGN) (“RetinalGeniX” or the “Company”) today announced that it has hired Virender Ahluwalia as Interim…
globenewswire.com RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board PETALUMA, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) today announced the addition of Stephen Tannenbaum to the Business…
globenewswire.com RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs PETALUMA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today announced that it has submitted two provisional patent…
globenewswire.com RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device PETALUMA, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today announced that it has contracted with Avania CRO to provide…
globenewswire.com RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration Proposed patient selection process is intended to reduce the cost and improve the safety and efficacy of patient candidate selection for ocular injections
globenewswire.com RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases Video Presentation Highlights Combining Genetic Markers with High-Resolution Retinal Imaging to Aid in Detection and Treatment of Blindness and Multiple Systemic Diseases Video Presentation…